Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Naturally Splendid Enterprises Ltd V.NSP.H

Alternate Symbol(s):  NSPDF

Naturally Splendid Enterprises Ltd. is a Canada-based company, which develops and distributes healthy lifestyle foods and products. The Company owns Prosnack Natural Foods Inc. (Prosnack Natural Foods), a food manufacturing facility. Prosnack Natural Foods focusses on nutritional bars, Chii Naturally Pure Hemp, which is a retail line of hemp food products, while Pawsitive FX is a line of all natural balms for dogs. The Company has also developed technologies for the extraction of healthy omega three and six oils, as well as a protein concentrate from hemp. It focuses on manufacturing and distributing an extensive line of plant-based, meat-alternative entrees. It offers functional foods under brands, such as Natera Sport, Natera Hemp Foods, CHII and Elevate Me.


TSXV:NSP.H - Post by User

Comment by Canucopeon Nov 30, 2021 9:01am
105 Views
Post# 34179293

RE:RE:Naturally Splendid Reports Third Quarter Results for 2021

RE:RE:Naturally Splendid Reports Third Quarter Results for 2021When you dont have money you cant do squat right... 
Wonder how management is going to pay themselves for Xmas.... ho ho ho 


SY3XElon wrote: Goodwin thinking the pandemic was over and no need to focus on this and now doing an about face says all I need to know about him. What a waste of several months. A trial could have been completed by now.

We have all been optimistic that the pandemic was on the decline which effected our decisions in how to proceed to trial. However, with the most recent developments surrounding the announcements by the World Health Organization as it relates to the latest mutation of the Covid virus, renewed efforts will be forthcoming looking to partner with experienced pharma companies to get Cavaltinib to trial.


<< Previous
Bullboard Posts
Next >>